Browse Category

NASDAQ:GEHC News 7 December 2025

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

Updated December 7, 2025 GE HealthCare Technologies Inc (Nasdaq: GEHC) is closing out 2025 with a flurry of announcements that signal an aggressive pivot toward AI-powered imaging, cloud software and long-term clinical alliances. From a $2.3 billion deal to acquire imaging software specialist Intelerad, to new NVIDIA-powered scanners and multi-year partnerships with the Mayo Clinic and the University of Rochester Medical Center, the company is trying to redefine itself as a digital-first medtech platform as it heads into 2026. GE HealthCare+3Reuters+3Yahoo Finance+3 At the same time, GE HealthCare has delivered better‑than‑expected third‑quarter earnings, raised its 2025 profit outlook and attracted

Stock Market Today

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop